Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Anti-Cancer Drug Design|August 1, 1990
Interactions between potential anti-tumour 2,5-bis(1-aziridinyl)-1,4-benzoquinone derivatives and glutathione: reductive activation, conjugation and DNA damageK J Lusthof, N J de Mol, L H Janssen, et al.The Journal of Organic Chemistry|June 26, 2001
Convergent synthesis of noncovalent metallodendrimers containing hydrophobic dendrons at the peripheryH J van Manen, R H Fokkens, N M Nibbering, et al.Archives of Biochemistry and Biophysics|February 15, 1990
Reductive activation of potential antitumor bis(aziridinyl)benzoquinones by xanthine oxidase: competition between oxygen reduction and quinone reductionK J Lusthof, W Richter, N J de Mol, et al.Journal of the American Chemical Society|August 2, 2001
Thermodynamic stabilities of linear and crinkled tapes and cyclic rosettes in melamine--cyanurate assemblies: a model descriptionA G Bielejewska, C E Marjo, L J Prins, et al.Anti-Cancer Drug Design|December 1, 1987
Novel bioreductive mitosene and mitosane analogues of mitomycin CW Verboom, D N Reinhoudt, B H Lammerink, et al.Anti-Cancer Drug Design|October 1, 1992
Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compoundsM Maliepaard, N J de Mol, L H Janssen, et al.Chemico-Biological Interactions|January 1, 1990
Covalent binding studies on the 14C-labeled antitumor compound 2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone radical in binding to DNA, and binding to proteins and bacterial macromolecules in situK J Lusthof, N J De Mol, L H Janssen, et al.Anticancer Research|July 1, 1986
Electrochemistry of potential bioreductive alkylating quinones: its use in the development of new aziridinylquinonesR J Driebergen, J J Holthuis, A Hulshoff, et al.Analytical Chemistry|February 5, 2000
Membrane characterization of anion-selective CHEMFETs by impedance spectroscopyM M Antonisse, B H Snellink-Ruël, R J Lugtenberg, et al.Journal of Medicinal Chemistry|July 23, 1993
Reductive activation of potential antitumor mitosene compoundsM Maliepaard, N J de Mol, L H Janssen, et al.Pageof 5